| CAS登錄號 | 中文名 | 英文名 | 分子結(jié)構(gòu)式 | 分子式 | 詳情 | 供應(yīng)商 |
| 183319-69-9 | 鹽酸埃羅替尼; N-(3-乙炔苯基)-[6,7-二(2-甲氧基乙氧基)]喹唑啉-4-胺鹽酸鹽 | Erlotinib hydrochloride; N-(3-Ethynylphenyl)[6,7-bis(2-methoxyethoxy)quinazolin-4-yl]amine hydrochloride; 6,7-Bis(2-methoxyethoxy)-4-(3-ethynylanilino)quinazoline hydrochloride; Tarceva |  | C22H24ClN3O4 | 詳情 | 供應(yīng)商 |
| 183321-74-6 | 埃羅替尼; N-(3-乙炔苯基)-[6,7-二(2-甲氧基乙氧基)]喹唑啉-4-胺 | Erlotinib; N-(3-Ethynylphenyl)[6,7-bis(2-methoxyethoxy)quinazolin-4-yl]amine; 4-[(3-Ethynylphenyl)amino]-6,7-bis(2-methoxyethoxy)quinazoline; Tarceva |  | C22H23N3O4 | 詳情 | 供應(yīng)商 |
| 184475-35-2 | 吉非替尼; N-(3-氯-4-氟苯基)-7-甲氧基-6-(3-嗎啉-4-丙氧基)喹唑啉-4-胺 | Gefitinib; N-(3-Chloro-4-fluoro-phenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine |  | C22H24ClFN4O3 | 詳情 | 供應(yīng)商 |
| 231277-92-2 | 拉帕替尼; N-[3-氯-4-[(3-氟苯基)甲氧基]苯基]-6-[5-[(2-甲磺酰乙基氨基)甲基]-2-呋喃基]喹唑啉-4-胺 | Lapatinib; N-[3-Chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[(2-methylsulfonylethylamino)methyl]-2-furyl]quinazolin-4-amine |  | C29H26ClFN4O4S | 詳情 | 供應(yīng)商 |
| 231278-20-9 | N-[3-氯-4-(3-氟芐氧基)苯基]-6-碘喹唑啉-4-胺 | N-[3-Chloro-4-(3-fluorobenzyloxy)phenyl]-6-iodoquinazolin-4-amine; 6-Iodo-4-[3-chloro-4-(3-fluorobenzyloxy)anilino]quinazoline; [3-Chloro-4-[(3-fluorobenzyl)oxy]phenyl](6-iodoquinazolin-4-yl)amine; 4-Quinazolinamine,N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-iodo |  | C21H14ClFIN3O | 詳情 | 供應(yīng)商 |
| 944549-41-1 | 6-溴-N-[3-氯-4-[(3-氟苯基)甲氧基]苯基]喹唑啉-4-胺; 6-溴-N-[3-氯-4-[(3-氟苯基)甲氧基]苯基]喹唑啉-4-胺 | 6-Bromo-N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]quinazolin-4-amine; 6-Bromo-N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]quinazolin-4-amine; N-(4-(3-fluorobenzyloxy)-3-chlorophenyl)-6-bromoquinazolin-4-amine |  | C21H14BrClFN3O | 詳情 | 供應(yīng)商 |